Philips India Ltd

Philips India Ltd

Fundamentals

Quick Insights

  • Market Leadership in Healthcare and Innovation: Philips leads in premium medical equipment in India, with strong capabilities in imaging technology and end-to-end medical centre solutions. Its Pune facility delivers world-class "Made in India" equipment. The innovation services segment, supporting KPNV's global tech needs, is poised for continued growth. Strong Financial Profile: Phlip India’s financial health is robust, with net worth of ₹1,474 crore and minimal debt as of March 31, 2024. Debt protection metrics are expected to remain strong, with no large debt-funded acquisitions or capex planned, apart from routine maintenance. Support from Parent Company: As a 96.13% subsidiary of KPNV, Phlilips benefits from strategic, technological, and managerial support. It imports most products from KPNV and remains integral to the parent’s expansion strategy in emerging markets.
Market Cap₹5,464.03 Cr
PE Ratio21.21
EPS₹44.8
Dividend Yield-
Book Value₹258.98 Cr
Debt/Equity-
Price/Book3.67
Price/Sales-
Industry PE-
Sales₹6,000.4 Cr
Profit After Tax₹257.5 Cr
Share Capital₹57.5 Cr
Shares Outstanding-
ISININE319A01016
SectorElectronics
Symbol-
About Company

Philips India is a significant subsidiary of the global healthcare and technology company, Koninklijke Philips NV. The company has a long history in the Indian market, having established itself over 120 years ago.

Latest News
No news available.
Strengths & Weaknesses

Strengths

Market Leadership in Healthcare and Innovation: Philips leads in premium medical equipment in India, with strong capabilities in imaging technology and end-to-end medical centre solutions. Its Pune facility delivers world-class "Made in India" equipment. The innovation services segment, supporting KPNV's global tech needs, is poised for continued growth.
Strong Financial Profile: Phlip India’s financial health is robust, with net worth of ₹1,474 crore and minimal debt as of March 31, 2024. Debt protection metrics are expected to remain strong, with no large debt-funded acquisitions or capex planned, apart from routine maintenance.
Support from Parent Company: As a 96.13% subsidiary of KPNV, Phlilips benefits from strategic, technological, and managerial support. It imports most products from KPNV and remains integral to the parent’s expansion strategy in emerging markets.

Weaknesses

Modest Profitability: Healthcare margins are expected to remain modest (5-6%), while personal care faces pricing pressure due to competition. However, the innovation services segment supports higher margins (~14%).
Competitive Pressures: Philip India faces intense competition in healthcare from GE and Siemens but benefits from a strong brand, extensive product portfolio, and broad distribution network.
Annual Reports
FY FY FY FY FY
Balance SheetFY2024FY2023FY2022FY2021FY2020FY2019
Equity Capital57.557.557.557.557.557.5
Reserves1432.11176.82220.02337.51994.72039.0
Total Equity1489.61234.32277.52395.02052.22096.5
Provisions320.0280.9237.8243.5302.280.0
Other Non-Current Liabilities801.1408.2430.0451.5405.6149.3
Total NC LiabilitiesTitle 6858.6465.7487.5509.0463.1206.8
Provisions73.863.595.4188.5100.182.9
Other Current Liabilities1247.51219.71302.41009.9933.71286.5
Total Current Liabilities1567.51500.61540.21253.41235.91366.5
Equity + Liabilities3915.73200.64305.24340.93751.23669.8
Fixed Assets (incl. WIP)830.3368.4371.0434.3428.3350.1
Other Non Current Assets731.5711.4763.9724.8828.0852.6
Total NC Assets1561.81079.81134.91159.11256.31202.7
Trade Receivables917.1740.1750.1574.1802.8804.8
Cash & Cash Equivalents272.8211.81315.9931.3857.8753.7
Other Current Assets1164.01168.91104.3778.3832.8906.0
Total Assets3915.73200.64305.24340.93751.23669.8
Profit & LossFY2024FY2023FY2022FY2021FY2020FY2019
Revenue from Operations6000.45734.05481.44842.75194.54912.1
Growth %5%5%13%-7%6%0
Operating Expenses5553.05330.25147.34471.34805.84515.1
Growth %4%4%15%-7%6%0
Operating Profit447.4403.8334.1371.4388.7397.0
Op. Profit Margin %7.5%7.0%6.1%7.7%7.5%8.1%
Other Income60.971.964.841.258.977.5
Interest Expense38.826.427.225.221.713.7
Depreciation142.6128.5138.4134.3127.3153.3
Exceptional Items 0.00.0-130.90.0-14.222.9
Profit Before Tax326.9320.8364.2253.1312.8284.6
Tax69.460.897.975.1169.192.0
Tax %1%1%2%2%3%2%
P/L from disc operations0.00.07.013.50.01.9
Profit After Tax257.5260.0259.3164.5143.7190.7
Growth %-1.0%0.3%57.6%14.5%-24.6%0
PAT %4%5%5%3%3%4%
Diluted EPS44.845.246.230.625.033.2
Shareholding Pattern
ColorShareholderHolding
Koninklijke Philips N.V (KPNV)96.13%
Others3.87%
Board of Directors
A.D.A. RatnamChairman and Non-Executive Independent Director
Bharath Ram Raman SeshaManaging Director
Harish ChawlaWhole - Time Director
Dev Kumar TripathyWhole - Time Director and Chief Financial Officer
Geetu Gidwani VermaNon-Executive Independent Director
Senior Management
Bharath Ram Raman SeshaManaging Director
Dev Kumar TripathyChief Financial Officer

FAQs – Buying Unlisted Shares

What are unlisted shares?+
Unlisted shares are stocks of companies that are not listed on any stock exchange like NSE or BSE. They are traded in the over-the-counter (OTC) market through dealers, brokers, and private transactions.
How is the price of an unlisted share decided?+
Unlike listed shares, there’s no central marketplace or live order book. Prices are based on demand and supply, dealer quotes, and recent transaction trends. This leads to price fragmentation — different dealers can quote very different prices for the same stock.
Why should I compare prices before buying?+
Because the same share can be available at a 5–20% price difference depending on the dealer. Not comparing means you could be paying a premium for no reason — directly impacting your returns.
Is buying unlisted shares risky?+
Yes, like any investment, unlisted shares carry risks — including liquidity risk (harder to sell), company performance risk, and price transparency issues. Comparing prices helps reduce one avoidable risk — overpaying.
How can I know if the price I’m getting is fair?+
You can check recent transaction prices, ask multiple dealers, and soon — use our price comparison platform to instantly see live market quotes.
What documents are required to buy unlisted shares?+
Typically: PAN Card Demat Account details KYC documents (address proof, ID proof)
How do I sell unlisted shares?+
You can sell them via a dealer, private buyer, or once the company gets listed on a stock exchange. Having access to multiple dealer quotes helps you get the best selling price.
Can dealers lose business if they don’t offer the best price?+
Absolutely. If an investor finds a better price elsewhere, they’ll switch — often for good. That’s why transparent pricing protects both investors and dealers.
How soon will I receive the shares after purchase?+
Usually within T+2 to T+7 days after payment and documentation, depending on the dealer and the company’s transfer process.
Do I need to be an accredited investor to buy unlisted shares?+
No, but you must meet the regulatory requirements under SEBI guidelines and have a valid Demat account.